☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Aged
Regeneron and Sanofi Report the US FDA's Acceptance of sBLA for Review of Dupixent to Treat Moderate-to-Severe Asthma in Children
March 4, 2021
Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older
August 24, 2020
Astellas' VESIcare LS (solifenacin succinate) Receives the US FDA's Approval to Treat Neurogenic Detrusor Overactivity (Ndo) In Pe...
May 27, 2020
Merck & Co's Dificid (fidaxomicin) Receives FDA's Approval to Treat Clostridioides difficile in Children Aged Six Months and Older
January 27, 2020
Vertex's Kalydeco (ivacaftor) Receives EC's Approval for Infants with Cystic Fibrosis with CFTR Gene Mutation Aged 6 to
December 11, 2019
Biogen's Spinraza (nusinersen) Receives NMPA (CFDA) Approval for Spinal Muscular Atrophy (SMA) Aged 6wks.
March 1, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.